Skip to content

Metabolomics of EUS-FNA specimens of pancreaticobiliary lesions

Metabolomics of EUS-FNA specimens of pancreaticobiliary lesions - Metabolomics of EUS-FNA specimens

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000045674
Enrollment
100
Registered
2021-10-18
Start date
2021-10-18
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreaticobiliary lesions

Interventions

None listed

Sponsors

Hokkaido University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1)Patients with suspected pancreaticobiliary lesion by blood or imaging tests (2)Patients who require EUS/ERCP/EUS-FNA (3)Patients who have given written informed consent for study recruitment

Exclusion criteria

Exclusion criteria: Patients judged by the physician in charge to be inappropriate as research subjects

Design outcomes

Primary

MeasureTime frame
Relationship between metabolomes of EUS-FNA specimens and overall survival

Countries

Japan

Contacts

Public ContactMasaki Kuwatani

Hokkaido University Hospital Department of Gastroenterology and Hepatology

mkuwatan@med.hokudai.ac.jp011-716-1161

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026